15 Apr 2026

NICE Quality Standards on Ovarian Cancer Update

A new statement on CA125 testing and ultrasound has been published today

This quality standard covers the identification and management of familial and genetic risk and the recognition and management of ovarian, fallopian tube and primary peritoneal cancer or borderline ovarian cancer in women, trans men and non-binary people aged 18 and over with female reproductive organs (ovaries, fallopian tubes or a uterus). It describes high-quality care in priority areas for improvement.

The quality standard does not cover risk management and decision-making support for men, trans women and non-binary adults born with male reproductive organs who have, or are at risk of having, a pathogenic variant associated with ovarian cancer.

More details>>

Finished reading?

Log CPD activity

×

Last chance - Win one of five passes to IBMS Congress 2027

Survey new.png

Our 2026 Membership Survey is still open, but time is running out. The survey closes on 17 August, so don't miss your opportunity to share your views.

Whether you're a current member or a former member, your feedback will help us better understand what's important to biomedical science professionals, identify where we can improve, and shape the future services, support and benefits we provide.

As a thank you, everyone who completes the survey can enter a prize draw to win one of five one-day delegate passes to IBMS Congress 2027.

Take the survey